Skip to main content
. 2020 Mar 23;17(6):2127. doi: 10.3390/ijerph17062127

Table 3.

Top 50 research domains emerged from exploratory factor analysis of all abstracts’ contents.

Name Keywords Eigen Value FREQ % Cases
Mental health summary Medical Outcomes Study (MOS); summary; mental; survey; physical; scores; medical; score; health related quality of life (HRQOL); outcomes; short form (SF) 26.1 4123 62.60%
Criteria; controlled trials Criteria; trials; objectives; controlled; main; evidence; performed; review; evaluate 1.9 2357 48.90%
The World Health Organization Quality of Life brief
(WHOQOL-BREF); Domain
WHOQOL; BREF; Domain; domains; world; version; QOL; psychological; social 3.3 2335 44.20%
Randomized; Controlled trial Randomized; trial; placebo; controlled; weeks; week; groups; primary; intervention 7.2 2312 39.30%
Cost-effectiveness; costs Cost; costs; effectiveness; effective; economic; model; year 1.9 1643 37.50%
Coping strategies; social support Coping; strategies; support; social 1.3 1522 37.10%
Depressive; anxiety and depression Depressive; depression; symptoms; anxiety; psychiatric; psychological 2.7 1722 36.10%
Reliability and validity; item scale Validity; reliability; item; items; instrument; factor; scales; measure; good; scale 2.2 1923 36.10%
Care access Access; services; care 1.3 1220 33.40%
Role functioning Role; function; cognitive; functioning 1.5 1025 27.30%
Viral load; count Load; viral; count; counts; cells 1.8 1384 27.00%
Literature; review Literature; review; evidence 5 919 24.10%
Sex; men and women Sexual; men; sex; women 1.8 1002 23.90%
Chronic conditions Conditions; chronic; diseases 1.6 840 23.40%
Stigma; disclosure Stigma; disclosure; perceived; negative 3.7 837 23.20%
Cross-sectional Sectional; cross; prevalence 2.5 1128 23.00%
Side effects Side; effects 1.5 815 22.80%
Follow-up period Period; follow; month; year 2.3 852 22.50%
Body mass; fat loss Mass; body; fat; weight; kg; loss; nutritional; exercise; testosterone; index 3.3 1169 21.40%
Drug users Users; methadone; drug; substance 2.3 766 21.00%
Outcome measures Outcome; measures 1.3 718 20.60%
Control Controls; control; intervention 1.7 712 20.10%
Anti; development Anti; development; resistance; therapeutic 1.2 712 19.70%
Palliative; cancer pain Palliative; cancer; advanced; pain 1.9 620 18.20%
Adherence to medication Medication; adherence 1.6 639 18.10%
Developed countries Countries; developed; settings 1.2 600 18.00%
Screening; early Screening; early; settings 1.2 500 15.50%
Combination Combination; response 1.3 416 13.50%
Demographic Demographic; characteristics 1.5 456 13.40%
Children Children; adoslescents; caregivers; family 1.7 499 13.30%
EuroQOL (EQ); HRQOL demension EQ; HRQOL; Dimensions 1.6 445 13.30%
Reduction Reduction; improvement 1.4 407 13.10%
Morbidity and mortality Mortality; morbidity 1.7 497 12.60%
Inhibitor; protease inhibitor (PI) regimens Inhibitor; PI; regimen; regimens 3.1 498 12.20%
Death Death; hospital 1.3 357 12.00%
Emotional Emotional; functional 1.3 358 11.80%
Exercise Exercise; activity; week 1.3 374 11.70%
Moderate to severe Severe; moderate; haemophilia 1.5 390 11.70%
Long-term Term; long 2.1 522 11.20%
Adverse effect Events; adverse 1.4 426 11.20%
Cytomegalovirus (CMV); Prophylaxis CMV; prophylaxis; infections 1.4 348 10.80%
South Africa South; Africa 2 344 8.60%
Food Food; people living with HIV (PLHIV); nutritional 1.3 225 6.90%
Facial Facial; satisfaction 1.3 177 5.90%
Hepatitis Hepatitis; hepatitis C virus (HCV) 1.9 215 5.60%
Sleep Sleep; fatigue 1.4 155 4.80%
Failure Failure 1.4 120 4.30%
Anemia Anemia 1.4 49 1.70%
Diarrhea Diarrhea 1.5 44 1.60%
Tuberculosis (TB) TB 1.4 38 1.40%